Pharmacovigilance Translation Services and Automation

When patient safety is on the line, every word matters. Our streamlined process translates your critical pharmacovigilance documents with unmatched accuracy, speed, and compliance, so you can focus on what matters most—protecting patient safety worldwide.

Contact Us
translation services in patient services

Achieve Global Compliance with Speed and Precision

  • Icon

Industry-Leading Technology

Leverage accurate translations using neural machine translation, secure client portals, and automated quality checks.

  • Icon

Efficient Translation Process

Maximize speed and precision with AI-powered initial translations followed by expert linguistic evaluation.

  • Icon Outbound Recruitment

Commitment to Quality

Guarantee quality with dual-review processes and cutting-edge automation to meet the highest global standards.

  • Icon

Comprehensive Safety Solutions

Go beyond translation with multilingual case triagedatabase reportingliterature monitoring, and redaction.

Accelerate Your Drug Safety Reporting

Deliver more reliable translations for all critical safety documents quickly. We make sure your documentation is precise and ready for submission.

Pharmacovigilance Document Translations

Translate all of your pharmacovigilance and drug safety materials with a global team of expert linguists. You can rely on TransPerfect for nuanced translations of risk management plans, clinical trial documents, regulatory submissions, and safety communications, DSURS, PADERs, PSURs, AERs and more.

AI-Powered Translation Efficiency

Accelerate pharmacovigilance translation with GlobalLink, TransPerfect’s groundbreaking artificial intelligence platform. GlobalLink adapts to medical terminology and context, recalls previously approved translations from translation memory for speed and consistency, flags discrepancies for review and provides expert linguistic refinement.

Regulatory Compliance Expertise

Meet the stringent requirements of the FDA, EMA, PMDA, and other regulatory authorities with translations aligned to global standards. Our expert linguists adhere to strict ISO 9001, ISO 18587, and ISO 17100 certification standards. All of our processes align with ASTM F2575-06, GDPR, ERES, GxP, 21 CFR Part 11, Annex 11, HITRUST, and other global pharma, biotech, and medical device compliance requirements.

Faster Translation and Cost Savings with AI

Leveraging AI for fast, cost-effective translations allows you to meet multilingual reporting requirements while reducing overall cycle times by 40%. A global team of on-demand translation experts provides an extra layer of quality assurance. For additional information on how to streamline the process, visit our Pharmacovigilance Solutions page. 

Trusted by Life Sciences Organizations Big and Small

Syneos Health
Gilead
Boehringer Ingelheim
Vertex
Alexion
St Jude Medical
Allergan
AstraZeneca
Biogen
BMS
Chiesi
Clario
CVS Health
Evidera/PPD
Fulgent
Hologic
ICON
Innovaderm
IQVIA
Johnson & Johnson logo
Labcorp
Bayer
Merck
MGH

Pharmacovigilance Document Translations

Accurate translations of pharmacovigilance documents are essential for maintaining regulatory adherence and ensuring safety. With expertise in translating key documents across the product lifecycle, from Pharmacovigilance System Master File (PSMF) documents through to commercialization communications. Our automated translations meet the specific requirements of regulatory agencies such as the FDA, EMA, and others. This system also includes a case triage process for timely categorization and prioritization of adverse event reports.

Popular pharmacovigilance and drug safety translation projects include:

Adverse Event and Safety Reporting

  • Case Report Forms (CRFs)
  • Individual Case Safety Reports (ICSRs)
  • Adverse Event Reports (AERs)
  • Serious Adverse Event Reports (SAE Reports)
  • Suspected Unexpected Serious Adverse Reactions (SUSARs)
  • Periodic Safety Update Reports (PSURs)
  • Periodic Adverse Drug Experience Reports (PADERs)
  • Signal Detection and Management Reports
  • Medication Error Reports
  • Vaccination Adverse Event Reports
  • Aggregate Signal Detection Summaries

Database Reporting and Case Management

Regulatory Submissions and Approvals

  • New Drug Applications (NDAs)
  • Investigational New Drug Safety Report (INDSRs)
  • Investigational New Drug Reporting (INDRs)
  • Pharmacovigilance Agreements (PVAs)
  • Risk Evaluation and Mitigation Strategies (REMS)
  • Development Safety Update Reports (DSURs)
  • Post-Marketing Surveillance Reports
  • Post-Authorization Safety Studies (PASS)
  • Health Authority Queries and Responses
  • Common Technical Document (CTD) Sections
  • Orphan Drug Designation Applications
  • Variations and Amendments

Risk Management and Mitigation

  • Pharmacovigilance Risk Management Plans (RMPs)
  • Benefit-Risk Assessment Reports
  • Field Safety Corrective Actions (FSCA) Notices
  • Safety Data Exchange Agreements (SDEAs)
  • Drug Safety Compliance Audit Reports
  • Post-Marketing Commitment Reports
  • Corrective and Preventative Action (CAPA) Reports
  • Safety Signal Assessment Reports

Clinical Documentation and Reporting

  • Clinical Study Reports (CSRs)
  • Nonclinical Study Reports
  • Aggregate Reports
  • Summary of Product Characteristics (SmPCs)
  • Protocol Deviation Reports
  • Investigator Brochures (IBs)
  • Clinical Trial Protocols

Patient and Healthcare Communications

  • Product Information Leaflets
  • Patient Safety Information
  • Direct Healthcare Professional Communications (DHCPs)
  • Dear Health Care Provider Letters (DHCP Letters)
  • Medication Guides (MedGuides)
  • Safety Narratives
  • Public Safety Announcements (PSAs)
  • Educational Materials for Healthcare Professionals
  • FAQs on Adverse Drug Reactions

Operational and Procedural Documentation

  • Global Pharmacovigilance Procedural Documents
  • Biological Product Deviation Reports (BPDRs)
  • Quality Defect Reports
  • Medical Device Adverse Event Reports
  • Local Safety Officer (LSO) Communications
  • Pharmacovigilance SOPs (Standard Operating Procedures)
  • Training Manuals for Pharmacovigilance Teams
  • Vendor and Partner Compliance Reports

Frequently Asked Questions

How do you ensure translation accuracy?

Our dual-review process involves advanced neural machine learning paired with linguistic review by life sciences specialists. Dual-review ensures translations are accurate and meet regulatory compliance and industry standards.

How do you handle confidential information?

Your data will be secure as our team adheres to the highest industry standards. In addition to encrypted data handling, automated PII redaction is utilized to ensure that any personal or clinical data is carefully redacted in compliance with privacy laws (such as GDPR or HIPAA).

Can you handle large-volume projects with tight deadlines?

Yes, our global team of life sciences linguists leverages TransPerfect's proprietary translation management system to handle enterprise volumes with tight deadlines. Our infrastructure is designed to uphold the highest standards of quality, accuracy, and regulatory compliance, regardless of project size and timeline.

Do you offer support for post-market surveillance translations?

Yes, we provide comprehensive translation services for all phases of the product lifecycle, including post-market surveillance. All translations will be in compliance with global regulations for adverse event reporting, periodic safety update reports (PSURs), or risk management documentation.

What is your process for integrating translations into our existing pharmacovigilance systems?

Our translation services seamlessly integrate into your existing systems, including eTMF (electronic trial master files) and ePRO (electronic patient-reported outcome) systems. Our technical team works closely with yours for a smooth integration, reducing workflow disruptions and maximizing efficiency.

How do you handle updates or revisions to translated documents?

We provide revision support for any updates or changes to your documents, whether it’s a regulatory change or a modification to your safety reporting requirements.

News and Press Releases

Structured Content Simplified: A Practical Guide for Veeva, XML, and Beyond

Life sciences organizations are facing increasing pressure to deliver accurate, compliant content across multiple channels and global markets faster than ever. To keep pace, many are turning to Structured or Component Content Management Systems (SCMS/CCMS), which allow teams to build content in modular, reusable components, rather than relying on static, document-based workflows. This modern approach makes it easier to link, version, and repurpose content across ...

Structured Content Simplified: A Practical Guide for Veeva, XML, and Beyond

Improving Learning Outcomes in Life Sciences Through Data-Driven Benchmarking

Whether onboarding new commercial staff, refreshing regulatory requirements, or preparing clinical teams for new protocols, the goal of training remains the same: equip people with the knowledge and skills they need to succeed. During our recent webinar, Jessica Peyser,...

Fast, Compliant, Centralized Translation in Action: Lessons from AbbVie & Immunovant

Due to high interest following our GlobalLink NEXT panel, we’re welcoming back Stacey Higgins, Associate Director, COA & Digital Implementation Team of AbbVie alongside Tihirah Harris, Sr Manager, Clinical Business Operations of Immunovant to share how and why they moved to a ...

Improving Learning Outcomes in Life Sciences Through Data-Driven Benchmarking

In life sciences, strong training programs are essential, but knowing whether they’re actually effective can be a difficult endeavor. In this session, Amanda Hernandez, Director of Sales Training & Effectiveness and Barrett Gaylord, Sales Training Lead of Telix ...

How Patients Discover Clinical Trial Websites: The Role of Localization in Search and Trust

Could localization be the key to improving patient recruitment in clinical trials?Recruiting participants for clinical trials is a critical step in bringing new therapies and treatments to market, but despite advances in digital outreach, the industry still faces major...

LifeSci Talks COA Series | Modernizing eCOA: Emulators, Backups, and the Future of Reporting

In this tech-forward episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, welcomes Indira Jain-Figueroa, Product Director at Evinova, for a deep dive into the ever-evolving landscape of eCOA development. Covering everything from cross ...

Rewriting the Rules of Informed Consent Development with AI

How AI and Structured Content Management Are Transforming the ICF ProcessInformed consent forms (ICFs) are essential to clinical trials, serving as the primary vehicle for communicating study information to participants in a clear, ethical, and compliant manner. Given...

Ready to translate your critical pharmacovigilance documents?

Discover how TransPerfect Life Sciences ensures compliance with regulatory standards, improves global reporting accuracy, and simplifies the translation of documents for pharmacovigilance and drug safety.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.